keytruda news - Search News

News

Merck, Verona and Keytruda

Reuters on MSN · 2h

Merck shells out $10 billion for Verona in bid to diversify beyond Keytruda

Merck said on Wednesday it will acquire UK-based Verona Pharma for about $10 billion, gaining a promising respiratory treatment as it faces pressure to diversify beyond its blockbuster cancer drug Keytruda.

Yahoo Finance · 2h

Merck will have 'a lot more work to do' after Verona deal

Merck (MRK) is spending about $10 billion to acquire Verona Pharma (VRNA) as the company looks to fill future revenue gaps. Evan Seigerman, managing director of biopharma equity research at BMO Capital Markets,

CNBC on MSN · 10h

Merck to buy Verona for $10 billion ahead of Keytruda patent expiration

CNBC's Angelica Peebles reports on themes emerging in the pharma space. Republican backs push to repeal part of Trump bill days after voting for it

12m

Kazia Reports Over 50% Cancer Cell Reduction In Early Data From Breast Cancer Trial, Stock Jumps

Kazia Therapeutics (NASDAQ:KZIA) on Wednesday reported preliminary results from the first patient in its Phase 1b trial ...

7h

Major deals involving U.S. drugmakers and biotechs over the past decade

Merck is acquiring UK-based Verona Pharma for about $10 billion, as part of the U.S. drugmaker's strategy to diversify beyond ...

9hon MSN

Two big reasons why buying Verona was crucial for Merck

Merck announces plans of buying Verona for a huge premium. VRNA deal could shield Merck from two major headwinds.

Pharmalittle: We’re reading about Trump’s latest tariff threat, a Merck deal, and lots more

President Trump threatened to impose up to 200% tariffs on pharmaceuticals imported into the U.S., but not immediately ...

6h

Factbox-Major Deals Involving U.S. Drugmakers and Biotechs Over the Past Decade

Globally, $105.3 billion worth of pharmaceuticals and biotech M&A deals have been inked so far in 2025, according to data ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results